ATM and breast cancer: Though A-T patients do not survive to an age at which BC generally occurs [29] A-T carriers (heterozygous for ATM mutations) appear to have an increased BC risk [30–33], with an estimated increased risk of 11% by the age of 50 and 30% by the age of 70 [34].